The European Commission has published a Restrictions Roadmap under REACH, describing this as “an important step forward to provide detailed information on all ongoing work on future restrictions under the EU chemical legislation”.
Jonathan Sharp, CFO of Environmental Litigation Group, looks at the impact on public health from increasing number of climate change-induced industrial disasters
Over the past decades, the discussion regarding climate change has shifted from estimated potential outcomes to far more urgent concerns regarding the reduction of its immediate adverse effects. Rising sea levels, coastline erosion and extreme weather events result directly from anthropogenic activities affecting global climate patterns.
Evonik’s Active Oxygens business line has released a new sustainability strategy for its hydrogen peroxide (H2O2), peracetic acid and persulfates. This includes steps to slash carbon emissions and increase resource efficiency in production, with the goal of achieving climate neutrality across the business line by 2040.
Three more companies have joined Together for Sustainability (TfS), the industry initiative for sustainable supply chains, bringing the total membership to 36. They are Germany- and Switzerland-based CDMO CABB; Mitsui, which is the first Japanese member; and Sennics, a Sinochem International subsidiary that makes polymer additives.
Cepsa Química has introduced the first products in its new line of sustainable chemicals. Both are derived from biomass and contain at least 68% sustainable or alternative carbon sources using the mass balance approach, with equivalent performance to existing products based on fossil sources.
These are NextLAB, which is a fossil-free linear alkylbenzene (LAB) for use in the production of biodegradable household laundry and cleaning products; and NextPhenol, which will replace phenol in automotive, construction and pharmaceutical applications.
The European Commission has revised certain information requirements for registering chemicals under REACH. It advised companies to start preparing as the changes will start to apply in October. Further advice will be issued in 2H and changes will be made accordingly in Iuclid.
The main changes concern requirements and specific rules for the adaptation of:
* In vitro and in vivo studies, when further studies are needed based on mutagenicity concerns
Ethisphere has named Lonza and Ecolab among the 136 publicly traded companies in 45 industries in 22 countries in its ‘World’s Most Ethical Companies’ listing. These have outperformed a comparable index of large cap companies by 24.6 percentage points over the past five calendar years.
Lonza, which appeared for the second time was one of thee in the Pharmaceuticals category, along with Pfizer and Eli Lilly. The company said that the aware “acknowledges its successful efforts in combining performance with integrity and accountability”.
